Note that resveratrol has shown to decrease expression of angiotensin-converting enzyme-2 (ACE2), which is the cellular entry point of SARS-CoV-2, in human SAT, but the clinical implications of resveratrol on COVID-19 are yet to be examined [210]. The gene discussed is ACE2; the disease is COVID-19.